Obesity associated disease risk: the role of inherent differences and location of adipose depots

References

[1] Kumar S, Kelly AS. Review of childhood obesity: from epidemiology, etiology, and comorbidities to clinical assessment and treatment. Mayo Clin Proc. 2017;92:251–65.10.1016/j.mayocp.2016.09.017Search in Google Scholar PubMed

[2] Goyal A, Nimmakayala KR, Zonszein J. Is there a paradox in obesity? Cardiol Rev. 2014;22:163–70.10.1097/CRD.0000000000000004Search in Google Scholar PubMed PubMed Central

[3] Sun X, Li P, Yang X, Li W, Qiu X, Zhu S. From genetics and epigenetics to the future of precision treatment for obesity. Gastroenterol Rep (Oxf). 2017;5:266–70.10.1093/gastro/gox033Search in Google Scholar PubMed PubMed Central

[4] Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011–2012. J Am Med Assoc. 2014;311:806–14.10.1001/jama.2014.732Search in Google Scholar PubMed PubMed Central

[5] Olds T, Maher C, Zumin S, Peneau S, Lioret S, Castetbon K, et al. Evidence that the prevalence of childhood overweight is plateauing: data from nine countries. Int J Pediatr Obes. 2011;6:342–60.10.3109/17477166.2011.605895Search in Google Scholar PubMed

[6] Ogden CL, Fakhouri TH, Carroll MD, Hales CM, Fryar CD, Li X, et al. Prevalence of Obesity among adults, by household income and education – United States, 2011–2014. MMWR Morb Mortal Wkly Rep. 2017;66:1369–73.10.15585/mmwr.mm6650a1Search in Google Scholar PubMed PubMed Central

[7] Isong IA, Rao SR, Bind MA, Avendano M, Kawachi I, Richmond TK. Racial and ethnic disparities in early childhood obesity. Pediatrics. 2018;141:1–13.10.1542/9781610022781-racialSearch in Google Scholar

[8] Bastien M, Poirier P, Lemieux I, Despres JP. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis. 2014;56:369–81.10.1016/j.pcad.2013.10.016Search in Google Scholar PubMed

[9] Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity among adults and youth: United States, 2015–2016. NCHS Data Brief. 2017;288:1–8.Search in Google Scholar

[10] Ogden CL, Carroll MD, Flegal KM. Prevalence of obesity in the United States. J Am Med Assoc. 2014;312:189–90.10.1001/jama.2014.6228Search in Google Scholar PubMed

[11] Muller MJ, Braun W, Enderle J, Bosy-Westphal A. Beyond BMI: conceptual issues related to overweight and obese patients. Obes Facts. 2016;9:193–205.10.1159/000445380Search in Google Scholar PubMed PubMed Central

[12] Zamboni M, Mazzali G, Zoico E, Harris TB, Meigs JB, Di Francesco V, et al. Health consequences of obesity in the elderly: a review of four unresolved questions. Int J Obes (Lond). 2005;29:1011–29.10.1038/sj.ijo.0803005Search in Google Scholar PubMed

[13] Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, et al. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr. 2005;81:341–54.10.1093/ajcn.81.2.341Search in Google Scholar PubMed

[14] Said A, Ghufran A. Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma. World J Clin Oncol. 2017;8:429–36.10.5306/wjco.v8.i6.429Search in Google Scholar PubMed PubMed Central

[15] Frasca D, Blomberg BB, Paganelli R. Aging, obesity, and inflammatory age-related diseases. Front Immunol. 2017;8:1745.10.3389/fimmu.2017.01745Search in Google Scholar PubMed PubMed Central

[16] Tchernof A, Despres JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93:359–404.10.1152/physrev.00033.2011Search in Google Scholar PubMed

[17] Lavie CJ, Schutter AD, Archer E, McAuley PA, Blair SN. Obesity and prognosis in chronic diseases – impact of cardiorespiratory fitness in the obesity paradox. Curr Sports Med Rep. 2014;13:240–5.10.1249/JSR.0000000000000067Search in Google Scholar PubMed

[18] Oliveros E, Somers VK, Sochor O, Goel K, Lopez-Jimenez F. The concept of normal weight obesity. Prog Cardiovasc Dis. 2014;56:426–33.10.1016/j.pcad.2013.10.003Search in Google Scholar PubMed

[19] Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med. 2008;168:1617–24.10.1001/archinte.168.15.1617Search in Google Scholar PubMed

[20] Shea JL, Randell EW, Sun G. The prevalence of metabolically healthy obese subjects defined by BMI and dual-energy X-ray absorptiometry. Obesity (Silver Spring). 2011;19:624–30.10.1038/oby.2010.174Search in Google Scholar PubMed

[21] Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008;168:1609–16.10.1001/archinte.168.15.1609Search in Google Scholar PubMed

[22] Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab. 2004;89:2569–75.10.1210/jc.2004-0165Search in Google Scholar PubMed

[23] Sims EA. Are there persons who are obese, but metabolically healthy? Metabolism. 2001;50:1499–504.10.1053/meta.2001.27213Search in Google Scholar PubMed

[24] Kennedy AP, Shea JL, Sun G. Comparison of the classification of obesity by BMI vs. dual-energy X-ray absorptiometry in the Newfoundland population. Obesity (Silver Spring). 2009;17:2094–9.10.1038/oby.2009.101Search in Google Scholar PubMed

[25] Gomez-Ambrosi J, Silva C, Galofre JC, Escalada J, Santos S, Millan D, et al. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes (Lond). 2012;36:286–94.10.1038/ijo.2011.100Search in Google Scholar PubMed

[26] Wannamethee SG, Shaper AG, Morris RW, Whincup PH. Measures of adiposity in the identification of metabolic abnormalities in elderly men. Am J Clin Nutr. 2005;81:1313–21.10.1093/ajcn/81.6.1313Search in Google Scholar PubMed

[27] Chan DC, Watts GF, Barrett PH, Burke V. Waist circumference, waist-to-hip ratio and body mass index as predictors of adipose tissue compartments in men. QJM. 2003;96:441–7.10.1093/qjmed/hcg069Search in Google Scholar PubMed

[28] Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr. 2005;81:555–63.10.1093/ajcn/81.3.555Search in Google Scholar PubMed

[29] Shea JL, King MT, Yi Y, Gulliver W, Sun G. Body fat percentage is associated with cardiometabolic dysregulation in BMI-defined normal weight subjects. Nutr Metab Cardiovasc Dis. 2012;22:741–7.10.1016/j.numecd.2010.11.009Search in Google Scholar PubMed

[30] Krebs NF, Himes JH, Jacobson D, Nicklas TA, Guilday P, Styne D. Assessment of child and adolescent overweight and obesity. Pediatrics. 2007;120(Suppl 4):S193–28.10.1542/peds.2007-2329DSearch in Google Scholar PubMed

[31] Choe SS, Huh JY, Hwang IJ, Kim JI, Kim JB. Adipose tissue remodeling: its role in energy metabolism and metabolic disorders. Front Endocrinol (Lausanne). 2016;7:30.10.3389/fendo.2016.00030Search in Google Scholar PubMed PubMed Central

[32] Foster MT, Pagliassotti MJ. Metabolic alterations following visceral fat removal and expansion: Beyond anatomic location. Adipocyte. 2012;1:192–9.10.4161/adip.21756Search in Google Scholar PubMed PubMed Central

[33] Harris RB, Leibel RL. Location, location, location. Cell Metab. 2008;7:359–61.10.1016/j.cmet.2008.04.007Search in Google Scholar PubMed

[34] Marinou K, Hodson L, Vasan SK, Fielding BA, Banerjee R, Brismar K, et al. Structural and functional properties of deep abdominal subcutaneous adipose tissue explain its association with insulin resistance and cardiovascular risk in men. Diabetes Care. 2014;37:821–9.10.2337/dc13-1353Search in Google Scholar PubMed

[35] Kwon H, Kim D, Kim JS. Body fat distribution and the risk of incident metabolic syndrome: a longitudinal cohort study. Sci Rep. 2017;7:10955.10.1038/s41598-017-09723-ySearch in Google Scholar PubMed PubMed Central

[36] Pellegrinelli V, Carobbio S, Vidal-Puig A. Adipose tissue plasticity: how fat depots respond differently to pathophysiological cues. Diabetologia. 2016;59:1075–88.10.1007/s00125-016-3933-4Search in Google Scholar PubMed PubMed Central

[37] Grundy SM, Brewer HB, Jr., Cleeman JI, Smith SC, Jr., Lenfant C, American Heart A, et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433–8.10.1161/01.CIR.0000111245.75752.C6Search in Google Scholar PubMed

[38] Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881–7.10.1007/978-0-387-32164-6_8Search in Google Scholar

[39] Monteiro R, Azevedo I. Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm. 2010;2010:1–10.10.1155/2010/289645Search in Google Scholar PubMed PubMed Central

[40] Guglielmi V, Sbraccia P. Obesity phenotypes: depot-differences in adipose tissue and their clinical implications. Eat Weight Disord. 2018;23:3–14.10.1007/s40519-017-0467-9Search in Google Scholar PubMed

[41] Booth A, Magnuson A, Foster M. Detrimental and protective fat: body fat distribution and its relation to metabolic disease. Horm Mol Biol Clin Investig. 2014;17:13–27.10.1515/hmbci-2014-0009Search in Google Scholar PubMed

[42] Rytka JM, Wueest S, Schoenle EJ, Konrad D. The portal theory supported by venous drainage-selective fat transplantation. Diabetes. 2011;60:56–63.10.2337/db10-0697Search in Google Scholar

[43] Tozzi M, Novak I. Purinergic receptors in adipose tissue as potential targets in metabolic disorders. Front Pharmacol. 2017;8:878.10.3389/fphar.2017.00878Search in Google Scholar

[44] Kim CS, Lee SC, Kim YM, Kim BS, Choi HS, Kawada T, et al. Visceral fat accumulation induced by a high-fat diet causes the atrophy of mesenteric lymph nodes in obese mice. Obesity (Silver Spring). 2008;16:1261–9.10.1038/oby.2008.55Search in Google Scholar

[45] Pond CM, Mattacks CA. In vivo evidence for the involvement of the adipose tissue surrounding lymph nodes in immune responses. Immunol Lett. 1998;63:159–67.10.1016/S0165-2478(98)00074-1Search in Google Scholar

[46] Corvera S, Gealekman O. Adipose tissue angiogenesis: impact on obesity and type-2 diabetes. Biochim Biophys Acta. 2014;1842:463–72.10.1016/j.bbadis.2013.06.003Search in Google Scholar PubMed PubMed Central

[47] Gregor MF, Hotamisligil GS. Thematic review series: adipocyte biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease. J Lipid Res. 2007;48:1905–14.10.1194/jlr.R700007-JLR200Search in Google Scholar PubMed

[48] Kwok KH, Lam KS, Xu A. Heterogeneity of white adipose tissue: molecular basis and clinical implications. Exp Mol Med. 2016;48:e215.10.1038/emm.2016.5Search in Google Scholar PubMed PubMed Central

[49] Jeffery E, Wing A, Holtrup B, Sebo Z, Kaplan JL, Saavedra-Pena R, et al. The adipose tissue microenvironment regulates depot-specific adipogenesis in obesity. Cell Metab. 2016;24:142–50.10.1016/j.cmet.2016.05.012Search in Google Scholar PubMed PubMed Central

[50] Opatrilova R, Caprnda M, Kubatka P, Valentova V, Uramova S, Nosal V, et al. Adipokines in neurovascular diseases. Biomed Pharmacother. 2017;98:424–32.10.1016/j.biopha.2017.12.074Search in Google Scholar PubMed

[51] Kwon H, Pessin JE. Adipokines mediate inflammation and insulin resistance. Front Endocrinol (Lausanne). 2013;4:71.10.3389/fendo.2013.00071Search in Google Scholar PubMed PubMed Central

[52] Luo L, Liu M. Adipose tissue in control of metabolism. J Endocrinol. 2016;231:R77–99.10.1530/JOE-16-0211Search in Google Scholar PubMed PubMed Central

[53] Smekal A, Vaclavik J. Adipokines and cardiovascular disease: a comprehensive review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017;161:31–40.10.5507/bp.2017.002Search in Google Scholar PubMed

[54] Booth A, Magnuson A, Fouts J, Foster MT. Adipose tissue: an endocrine organ playing a role in metabolic regulation. Horm Mol Biol Clin Investig. 2016;26:25–42.10.1515/hmbci-2015-0073Search in Google Scholar PubMed

[55] Lee BC, Lee J. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Biochim Biophys Acta. 2014;1842:446–62.10.1016/j.bbadis.2013.05.017Search in Google Scholar PubMed PubMed Central

[56] Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11:85–97.10.1038/nri2921Search in Google Scholar PubMed PubMed Central

[57] Kocot J, Dziemidok P, Kielczykowska M, Hordyjewska A, Szczesniak G, Musik I. Adipokine profile in patients with type 2 diabetes depends on degree of obesity. Med Sci Monit. 2017;23:4995–5004.10.12659/MSM.904318Search in Google Scholar PubMed PubMed Central

[58] Esteve Rafols M. Adipose tissue: cell heterogeneity and functional diversity. Endocrinol Nutr. 2014;61:100–12.10.1016/j.endoen.2014.02.001Search in Google Scholar

[59] Zhou Y, Zhang B, Hao C, Huang X, Li X, Huang Y, et al. Omentin-A Novel Adipokine in Respiratory Diseases. Int J Mol Sci. 2017;19:1–16.10.3390/ijms19010073Search in Google Scholar PubMed PubMed Central

[60] Chung HS, Choi KM. Adipokines and myokines: a pivotal role in metabolic and cardiovascular disorders. Curr Med Chem. 2017. [Epub ahead of print].10.2174/0929867325666171205144627Search in Google Scholar PubMed

[61] Booth A, Magnuson A, Fouts J, Foster M. Adipose tissue, obesity and adipokines: role in cancer promotion. Horm Mol Biol Clin Investig. 2015;21:57–74.10.1515/hmbci-2014-0037Search in Google Scholar PubMed

[62] Zhou JY, Chan L, Zhou SW. Omentin: linking metabolic syndrome and cardiovascular disease. Curr Vasc Pharmacol. 2014;12:136–43.10.2174/1570161112999140217095038Search in Google Scholar PubMed

[63] Sitticharoon C, Nway NC, Chatree S, Churintaraphan M, Boonpuan P, Maikaew P. Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors. Peptides. 2014;62:164–75.10.1016/j.peptides.2014.10.006Search in Google Scholar PubMed

[64] Barchetta I, Cimini FA, Capoccia D, De Gioannis R, Porzia A, Mainiero F, et al. WISP1 is a marker of systemic and adipose tissue inflammation in dysmetabolic subjects with or without type 2 diabetes. J Endocr Soc. 2017;1:660–70.10.1210/js.2017-00108Search in Google Scholar PubMed PubMed Central

[65] Maiese K, Chong ZZ, Shang YC, Wang S. Targeting disease through novel pathways of apoptosis and autophagy. Expert Opin Ther Targets. 2012;16:1203–14.10.1517/14728222.2012.719499Search in Google Scholar PubMed PubMed Central

[66] Berschneider B, Konigshoff M. WNT1 inducible signaling pathway protein 1 (WISP1): a novel mediator linking development and disease. Int J Biochem Cell Biol. 2011;43:306–9.10.1016/j.biocel.2010.11.013Search in Google Scholar PubMed

[67] Maiese K. WISP1: Clinical insights for a proliferative and restorative member of the CCN family. Curr Neurovasc Res. 2014;11:378–89.10.2174/1567202611666140912115107Search in Google Scholar PubMed PubMed Central

[68] Belchamber KB, Donnelly LE. Macrophage dysfunction in respiratory disease. Results Probl Cell Differ. 2017;62:299–313.10.1007/978-3-319-54090-0_12Search in Google Scholar PubMed

[69] Huang X, Yang Z. Resistin’s, obesity and insulin resistance: the continuing disconnect between rodents and humans. J Endocrinol Invest. 2016;39:607–15.10.1007/s40618-015-0408-2Search in Google Scholar PubMed

[70] Jonas MI, Kurylowicz A, Bartoszewicz Z, Lisik W, Jonas M, Domienik-Karlowicz J, et al. Adiponectin/resistin interplay in serum and in adipose tissue of obese and normal-weight individuals. Diabetol Metab Syndr. 2017;9:95.10.1186/s13098-017-0293-2Search in Google Scholar PubMed PubMed Central

[71] Curat CA, Wegner V, Sengenes C, Miranville A, Tonus C, Busse R, et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia. 2006;49:744–7.10.1007/s00125-006-0173-zSearch in Google Scholar PubMed

[72] Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science. 2005;307:426–30.10.1126/science.1097243Search in Google Scholar PubMed

[73] Revollo JR, Korner A, Mills KF, Satoh A, Wang T, Garten A, et al. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab. 2007;6:363–75.10.1016/j.cmet.2007.09.003Search in Google Scholar PubMed PubMed Central

[74] Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol. 1994;14:1431–7.10.1128/MCB.14.2.1431Search in Google Scholar

[75] Jia SH, Li Y, Parodo J, Kapus A, Fan L, Rotstein OD, et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest. 2004;113:1318–27.10.1172/JCI19930Search in Google Scholar PubMed PubMed Central

[76] Moschen AR, Kaser A, Enrich B, Mosheimer B, Theurl M, Niederegger H, et al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol. 2007;178:1748–58.10.4049/jimmunol.178.3.1748Search in Google Scholar PubMed

[77] Ognjanovic S, Bryant-Greenwood GD. Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes. Am J Obstet Gynecol. 2002;187:1051–8.10.1067/mob.2002.126295Search in Google Scholar PubMed

[78] Ye SQ, Simon BA, Maloney JP, Zambelli-Weiner A, Gao L, Grant A, et al. Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med. 2005;171:361–70.10.1164/rccm.200404-563OCSearch in Google Scholar PubMed

[79] Oki K, Yamane K, Kamei N, Nojima H, Kohno N. Circulating visfatin level is correlated with inflammation, but not with insulin resistance. Clin Endocrinol (Oxf). 2007;67:796–800.10.1111/j.1365-2265.2007.02966.xSearch in Google Scholar PubMed

[80] Houde AA, Legare C, Biron S, Lescelleur O, Biertho L, Marceau S, et al. Leptin and adiponectin DNA methylation levels in adipose tissues and blood cells are associated with BMI, waist girth and LDL-cholesterol levels in severely obese men and women. BMC Med Genet. 2015;16:29.10.1186/s12881-015-0174-1Search in Google Scholar PubMed PubMed Central

[81] Fantuzzi G. Adiponectin in inflammatory and immune-mediated diseases. Cytokine. 2013;64:1–10.10.1016/j.cyto.2013.06.317Search in Google Scholar PubMed PubMed Central

[82] Xia JY, Sun K, Hepler C, Ghaben AL, Gupta RK, An YA, et al. Acute loss of adipose tissue-derived adiponectin triggers immediate metabolic deterioration in mice. Diabetologia. 2017. [Epub ahead of print].10.1007/s00125-017-4516-8Search in Google Scholar PubMed PubMed Central

[83] Nway NC, Sitticharoon C, Chatree S, Maikaew P. Correlations between the expression of the insulin sensitizing hormones, adiponectin, visfatin, and omentin, and the appetite regulatory hormone, neuropeptide Y and its receptors in subcutaneous and visceral adipose tissues. Obes Res Clin Pract. 2016;10:256–63.10.1016/j.orcp.2015.05.007Search in Google Scholar

[84] Wang Y, Lam KS, Xu JY, Lu G, Xu LY, Cooper GJ, et al. Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem. 2005;280:18341–7.10.1074/jbc.M501149200Search in Google Scholar

[85] Ge Q, Ryken L, Noel L, Maury E, Brichard SM. Adipokines identified as new downstream targets for adiponectin: lessons from adiponectin-overexpressing or -deficient mice. Am J Physiol Endocrinol Metab. 2011;301:E326–35.10.1152/ajpendo.00153.2011Search in Google Scholar

[86] Brenner D, Blaser H, Mak TW. Regulation of tumour necrosis factor signalling: live or let die. Nat Rev Immunol. 2015;15:362–74.10.1038/nri3834Search in Google Scholar

[87] Huber R, Bikker R, Welz B, Christmann M, Brand K. TNF tolerance in monocytes and macrophages: characteristics and molecular mechanisms. J Immunol Res. 2017;2017:9570129.10.1155/2017/9570129Search in Google Scholar

[88] Chen GY, Nunez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010;10:826–37.10.1038/nri2873Search in Google Scholar

[89] Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 2004;15:2792–800.10.1097/01.ASN.0000141966.69934.21Search in Google Scholar

[90] Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995;95:2409–15.10.1172/JCI117936Search in Google Scholar

[91] Tsigos C, Kyrou I, Chala E, Tsapogas P, Stavridis JC, Raptis SA, et al. Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. Metabolism. 1999;48:1332–35.10.1016/S0026-0495(99)90277-9Search in Google Scholar

[92] Winkler G, Kiss S, Keszthelyi L, Sapi Z, Ory I, Salamon F, et al. Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level. Eur J Endocrinol. 2003;149:129–35.10.1530/eje.0.1490129Search in Google Scholar PubMed

[93] Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA. 1994;91:4854–8.10.1073/pnas.91.11.4854Search in Google Scholar PubMed PubMed Central

[94] Grunfeld C, Feingold KR. The metabolic effects of tumor necrosis factor and other cytokines. Biotherapy. 1991;3:143–58.10.1007/BF02172087Search in Google Scholar PubMed

[95] Hotamisligil GS. Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord. 2003;27(Suppl 3):S53–5.10.1038/sj.ijo.0802502Search in Google Scholar PubMed

[96] Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, et al. A central role for JNK in obesity and insulin resistance. Nature. 2002;420:333–6.10.1038/nature01137Search in Google Scholar PubMed

[97] Jin D, Sun J, Huang J, He Y, Yu A, Yu X, et al. TNF-alpha reduces g0s2 expression and stimulates lipolysis through PPAR-gamma inhibition in 3T3-L1 adipocytes. Cytokine. 2014;69:196–205.10.1016/j.cyto.2014.06.005Search in Google Scholar PubMed

[98] Chen Z, Yu R, Xiong Y, Du F, Zhu S. A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease. Lipids Health Dis. 2017;16:203.10.1186/s12944-017-0572-9Search in Google Scholar PubMed PubMed Central

[99] Tan X, Cao Z, Li M, Xu E, Wang J, Xiao Y. TNF-alpha downregulates CIDEC via MEK/ERK pathway in human adipocytes. Obesity (Silver Spring). 2016;24:1070–80.10.1002/oby.21436Search in Google Scholar PubMed

[100] Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW, Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796–808.10.1172/JCI200319246Search in Google Scholar

[101] Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab. 1997;82:4196–200.10.1210/jc.82.12.4196Search in Google Scholar

[102] Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998;83:847–50.10.1210/jc.83.3.847Search in Google Scholar

[103] Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab. 2000;85:3338–42.10.1210/jcem.85.9.6839Search in Google Scholar

[104] Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J. 1990;265:621–36.10.1042/bj2650621Search in Google Scholar PubMed PubMed Central

[105] Covarrubias AJ, Horng T. IL-6 strikes a balance in metabolic inflammation. Cell Metab. 2014;19:898–9.10.1016/j.cmet.2014.05.009Search in Google Scholar

[106] Mauer J, Chaurasia B, Goldau J, Vogt MC, Ruud J, Nguyen KD, et al. Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nat Immunol. 2014;15:423–30.10.1038/ni.2865Search in Google Scholar

[107] Braune J, Weyer U, Hobusch C, Mauer J, Bruning JC, Bechmann I, et al. IL-6 Regulates M2 Polarization and Local Proliferation of Adipose Tissue Macrophages in Obesity. J Immunol. 2017;198:2927–34.10.4049/jimmunol.1600476Search in Google Scholar

[108] Plata-Salaman CR. Immunoregulators in the nervous system. Neurosci Biobehav Rev. 1991;15:185–215.10.1016/S0149-7634(05)80001-6Search in Google Scholar

[109] Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest. 2006;116:1494–505.10.1172/JCI26498Search in Google Scholar PubMed PubMed Central

[110] Seijkens T, Kusters P, Chatzigeorgiou A, Chavakis T, Lutgens E. Immune cell crosstalk in obesity: a key role for costimulation? Diabetes. 2014;63:3982–91.10.2337/db14-0272Search in Google Scholar PubMed

[111] Kamei N, Tobe K, Suzuki R, Ohsugi M, Watanabe T, Kubota N, et al. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem. 2006;281:26602–14.10.1074/jbc.M601284200Search in Google Scholar PubMed

[112] Huh JY, Park YJ, Ham M, Kim JB. Crosstalk between adipocytes and immune cells in adipose tissue inflammation and metabolic dysregulation in obesity. Mol Cells. 2014;37:365–71.10.14348/molcells.2014.0074Search in Google Scholar PubMed PubMed Central

[113] Bruun JM, Lihn AS, Pedersen SB, Richelsen B. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab. 2005;90:2282–9.10.1210/jc.2004-1696Search in Google Scholar PubMed

[114] Guzman-Flores JM, Lopez-Briones S. [Cells of innate and adaptive immunity in type 2 diabetes and obesity]. Gac Med Mex. 2012;148:381–9.Search in Google Scholar

[115] Lynch L. Adipose invariant natural killer T cells. Immunology. 2014;142:337–46.10.1111/imm.12269Search in Google Scholar PubMed PubMed Central

[116] Ferrante AW, Jr. The immune cells in adipose tissue. Diabetes Obes Metab. 2013;15(Suppl 3):34–8.10.1111/dom.12154Search in Google Scholar PubMed PubMed Central

[117] Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A, et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med. 2009;15:930–9.10.1038/nm.2002Search in Google Scholar PubMed PubMed Central

[118] Wu D, Molofsky AB, Liang HE, Ricardo-Gonzalez RR, Jouihan HA, Bando JK, et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science. 2011;332:243–7.10.1126/science.1201475Search in Google Scholar PubMed PubMed Central

[119] Wu L, Parekh VV, Gabriel CL, Bracy DP, Marks-Shulman PA, Tamboli RA, et al. Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice. Proc Natl Acad Sci USA. 2012;109:E1143–52.10.1073/pnas.1200498109Search in Google Scholar PubMed PubMed Central

[120] Ohmura K, Ishimori N, Ohmura Y, Tokuhara S, Nozawa A, Horii S, et al. Natural killer T cells are involved in adipose tissues inflammation and glucose intolerance in diet-induced obese mice. Arterioscler Thromb Vasc Biol. 2010;30:193–9.10.1161/ATVBAHA.109.198614Search in Google Scholar PubMed

[121] Lynch L, Nowak M, Varghese B, Clark J, Hogan AE, Toxavidis V, et al. Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity. 2012;37:574–87.10.1016/j.immuni.2012.06.016Search in Google Scholar PubMed PubMed Central

[122] Ji Y, Sun S, Xia S, Yang L, Li X, Qi L. Short term high fat diet challenge promotes alternative macrophage polarization in adipose tissue via natural killer T cells and interleukin-4. J Biol Chem. 2012;287:24378–86.10.1074/jbc.M112.371807Search in Google Scholar PubMed PubMed Central

[123] Schipper HS, Rakhshandehroo M, van de Graaf SF, Venken K, Koppen A, Stienstra R, et al. Natural killer T cells in adipose tissue prevent insulin resistance. J Clin Invest. 2012;122:3343–54.10.1172/JCI62739Search in Google Scholar PubMed PubMed Central

[124] Ji Y, Sun S, Xu A, Bhargava P, Yang L, Lam KS, et al. Activation of natural killer T cells promotes M2 Macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity. J Biol Chem. 2012;287:13561–71.10.1074/jbc.M112.350066Search in Google Scholar PubMed PubMed Central

[125] de Heredia FP, Gomez-Martinez S, Marcos A. Obesity, inflammation and the immune system. Proc Nutr Soc. 2012;71:332–8.10.1017/S0029665112000092Search in Google Scholar PubMed

[126] Wajchenberg BL, Giannella-Neto D, da Silva ME, Santos RF. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm Metab Res. 2002;34:616–21.10.1055/s-2002-38256Search in Google Scholar

[127] Jensen MD. Health consequences of fat distribution. Horm Res. 1997;48(Suppl 5):88–92.10.1159/000191335Search in Google Scholar

[128] Ostman J, Arner P, Engfeldt P, Kager L. Regional differences in the control of lipolysis in human adipose tissue. Metabolism. 1979;28:1198–205.10.1016/0026-0495(79)90131-8Search in Google Scholar

[129] Rebuffe-Scrive M, Andersson B, Olbe L, Bjorntorp P. Metabolism of adipose tissue in intraabdominal depots of nonobese men and women. Metabolism. 1989;38:453–8.10.1016/0026-0495(89)90198-4Search in Google Scholar

[130] Hellmer J, Marcus C, Sonnenfeld T, Arner P. Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells. J Clin Endocrinol Metab. 1992;75:15–20.10.1210/jcem.75.1.1320047Search in Google Scholar

[131] Arner P, Hellstrom L, Wahrenberg H, Bronnegard M. Beta-adrenoceptor expression in human fat cells from different regions. J Clin Invest. 1990;86:1595–600.10.1172/JCI114880Search in Google Scholar PubMed PubMed Central

[132] Vikman HL, Savola JM, Raasmaja A, Ohisalo JJ. Alpha 2A-adrenergic regulation of cyclic AMP accumulation and lipolysis in human omental and subcutaneous adipocytes. Int J Obes Relat Metab Disord. 1996;20:185–9.Search in Google Scholar

[133] Bergman RN. Non-esterified fatty acids and the liver: why is insulin secreted into the portal vein? Diabetologia. 2000;43:946–52.10.1007/s001250051474Search in Google Scholar PubMed

[134] Bjorntorp P. Metabolic implications of body fat distribution. Diabetes Care. 1991;14:1132–43.10.2337/diacare.14.12.1132Search in Google Scholar PubMed

[135] Foster MT, Shi H, Seeley RJ, Woods SC. Removal of intra-abdominal visceral adipose tissue improves glucose tolerance in rats: role of hepatic triglyceride storage. Physiol Behav. 2011;104:845–54.10.1016/j.physbeh.2011.04.064Search in Google Scholar PubMed PubMed Central

[136] Foster MT, Shi H, Softic S, Kohli R, Seeley RJ, Woods SC. Transplantation of non-visceral fat to the visceral cavity improves glucose tolerance in mice: investigation of hepatic lipids and insulin sensitivity. Diabetologia. 2011;54:2890–9.10.1007/s00125-011-2259-5Search in Google Scholar PubMed PubMed Central

[137] Niesler CU, Siddle K, Prins JB. Human preadipocytes display a depot-specific susceptibility to apoptosis. Diabetes. 1998;47:1365–8.10.2337/diab.47.8.1365Search in Google Scholar PubMed

[138] Montague CT, Prins JB, Sanders L, Zhang J, Sewter CP, Digby J, et al. Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes. 1998;47:1384–91.10.2337/diabetes.47.9.1384Search in Google Scholar

[139] Hauner H, Wabitsch M, Pfeiffer EF. Differentiation of adipocyte precursor cells from obese and nonobese adult women and from different adipose tissue sites. Horm Metab Res Suppl. 1988;19:35–9.Search in Google Scholar

[140] Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell. 1994;79:1147–56.10.1016/0092-8674(94)90006-XSearch in Google Scholar

[141] Pasarica M, Sereda OR, Redman LM, Albarado DC, Hymel DT, Roan LE, et al. Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes. 2009;58:718–25.10.2337/db08-1098Search in Google Scholar PubMed PubMed Central

[142] Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest. 2011;121:2094–101.10.1172/JCI45887Search in Google Scholar PubMed PubMed Central

[143] Farb MG, Ganley-Leal L, Mott M, Liang Y, Ercan B, Widlansky ME, et al. Arteriolar function in visceral adipose tissue is impaired in human obesity. Arterioscler Thromb Vasc Biol. 2012;32:467–73.10.1161/ATVBAHA.111.235846Search in Google Scholar PubMed PubMed Central

[144] Gealekman O, Guseva N, Hartigan C, Apotheker S, Gorgoglione M, Gurav K, et al. Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity. Circulation. 2011;123:186–94.10.1161/CIRCULATIONAHA.110.970145Search in Google Scholar PubMed PubMed Central

[145] Fresno M, Alvarez R, Cuesta N. Toll-like receptors, inflammation, metabolism and obesity. Arch Physiol Biochem. 2011;117:151–64.10.3109/13813455.2011.562514Search in Google Scholar PubMed

[146] Magnuson AM, Regan DP, Fouts JK, Booth AD, Dow SW, Foster MT. Diet-induced obesity causes visceral, but not subcutaneous, lymph node hyperplasia via increases in specific immune cell populations. Cell Prolif. 2017;50:1–8.10.1111/cpr.12365Search in Google Scholar PubMed PubMed Central

[147] Kumari M, Heeren J, Scheja L. Regulation of immunometabolism in adipose tissue. Semin Immunopathol. 2018;40:189–202.10.1007/s00281-017-0668-3Search in Google Scholar PubMed

[148] Despres JP. Abdominal obesity and cardiovascular disease: is inflammation the missing link? Can J Cardiol. 2012;28:642–52.10.1016/j.cjca.2012.06.004Search in Google Scholar PubMed

[149] Lopes HF, Correa-Giannella ML, Consolim-Colombo FM, Egan BM. Visceral adiposity syndrome. Diabetol Metab Syndr. 2016;8:40.10.1186/s13098-016-0156-2Search in Google Scholar PubMed PubMed Central

[150] McNelis JC, Olefsky JM. Macrophages, immunity, and metabolic disease. Immunity. 2014;41:36–48.10.1016/j.immuni.2014.05.010Search in Google Scholar PubMed

[151] Li C, Xu MM, Wang K, Adler AJ, Vella AT, Zhou B. Macrophage polarization and meta-inflammation. Transl Res. 2018;191:29–44.10.1016/j.trsl.2017.10.004Search in Google Scholar PubMed PubMed Central

[152] McGillicuddy FC, Harford KA, Reynolds CM, Oliver E, Claessens M, Mills KH, Roche HM. Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis. Diabetes. 2011;60:1688–98.10.2337/db10-1278Search in Google Scholar PubMed PubMed Central

[153] Finucane OM, Reynolds CM, McGillicuddy FC, Harford KA, Morrison M, Baugh J, et al. Macrophage migration inhibitory factor deficiency ameliorates high-fat diet induced insulin resistance in mice with reduced adipose inflammation and hepatic steatosis. PLoS One. 2014;9:e113369.10.1371/journal.pone.0113369Search in Google Scholar PubMed PubMed Central

[154] Finucane OM, Reynolds CM, McGillicuddy FC, Roche HM. Insights into the role of macrophage migration inhibitory factor in obesity and insulin resistance. Proc Nutr Soc. 2012;71:622-633.10.1017/S0029665112000730Search in Google Scholar PubMed

[155] Suganami T, Ogawa Y. Adipose tissue macrophages: their role in adipose tissue remodeling. J Leukoc Biol. 2010;88:33–9.10.1189/jlb.0210072Search in Google Scholar PubMed

[156] Talukdar S, Oh DY, Bandyopadhyay G, Li D, Xu J, McNelis J, et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med. 2012;18:1407–12.10.1038/nm.2885Search in Google Scholar PubMed PubMed Central

[157] Liu J, Divoux A, Sun J, Zhang J, Clement K, Glickman JN, et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med. 2009;15:940–5.10.1038/nm.1994Search in Google Scholar PubMed PubMed Central

[158] Sell H, Habich C, Eckel J. Adaptive immunity in obesity and insulin resistance. Nat Rev Endocrinol. 2012;8:709–16.10.1038/nrendo.2012.114Search in Google Scholar PubMed

[159] Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med. 2009;15:914–20.10.1038/nm.1964Search in Google Scholar PubMed

[160] Harford KA, Reynolds CM, McGillicuddy FC, Roche HM. Fats, inflammation and insulin resistance: insights to the role of macrophage and T-cell accumulation in adipose tissue. Proc Nutr Soc. 2011;70:408–17.10.1017/S0029665111000565Search in Google Scholar PubMed

[161] Becker M, Levings MK, Daniel C. Adipose-tissue regulatory T cells: critical players in adipose-immune crosstalk. Eur J Immunol. 2017;47:1867–74.10.1002/eji.201646739Search in Google Scholar PubMed

[162] Rocha VZ, Folco EJ, Sukhova G, Shimizu K, Gotsman I, Vernon AH, et al. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res. 2008;103:467–76.10.1161/CIRCRESAHA.108.177105Search in Google Scholar PubMed PubMed Central

[163] Stefanovic-Racic M, Yang X, Turner MS, Mantell BS, Stolz DB, Sumpter TL, et al. Dendritic cells promote macrophage infiltration and comprise a substantial proportion of obesity-associated increases in CD11c+ cells in adipose tissue and liver. Diabetes. 2012;61:2330–9.10.2337/db11-1523Search in Google Scholar PubMed PubMed Central

[164] Winer DA, Winer S, Shen L, Wadia PP, Yantha J, Paltser G, et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med. 2011;17:610–7.10.1038/nm.2353Search in Google Scholar PubMed PubMed Central

[165] DeFuria J, Belkina AC, Jagannathan-Bogdan M, Snyder-Cappione J, Carr JD, Nersesova YR, et al. B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci USA. 2013;110:5133–8.10.1073/pnas.1215840110Search in Google Scholar PubMed PubMed Central

[166] Tobin LM, Mavinkurve M, Carolan E, Kinlen D, O’Brien EC, Little MA, et al. NK cells in childhood obesity are activated, metabolically stressed, and functionally deficient. JCI Insight. 2017;2:1–9.10.1172/jci.insight.94939Search in Google Scholar PubMed PubMed Central

[167] Viel S, Besson L, Charrier E, Marcais A, Disse E, Bienvenu J, et al. Alteration of Natural Killer cell phenotype and function in obese individuals. Clin Immunol. 2017;177:12–17.10.1016/j.clim.2016.01.007Search in Google Scholar PubMed

[168] Campbell KS, Hasegawa J. Natural killer cell biology: an update and future directions. J Allergy Clin Immunol. 2013;132:536–44.10.1016/j.jaci.2013.07.006Search in Google Scholar PubMed PubMed Central

[169] Klein S, Allison DB, Heymsfield SB, Kelley DE, Leibel RL, Nonas C, et al. Waist circumference and cardiometabolic risk: a consensus statement from shaping America’s health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Diabetes Care. 2007;30:1647–52.10.2337/dc07-9921Search in Google Scholar

[170] Tchkonia T, Thomou T, Zhu Y, Karagiannides I, Pothoulakis C, Jensen MD, et al. Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab. 2013;17:644–56.10.1016/j.cmet.2013.03.008Search in Google Scholar

[171] Kelley DE, Thaete FL, Troost F, Huwe T, Goodpaster BH. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab. 2000;278:E941–8.10.1152/ajpendo.2000.278.5.E941Search in Google Scholar

[172] Karpe F, Pinnick KE. Biology of upper-body and lower-body adipose tissue – link to whole-body phenotypes. Nat Rev Endocrinol. 2015;11:90–100.10.1038/nrendo.2014.185Search in Google Scholar

[173] Manolopoulos KN, Karpe F, Frayn KN. Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond). 2010;34:949–59.10.1038/ijo.2009.286Search in Google Scholar

[174] Snijder MB, Dekker JM, Visser M, Bouter LM, Stehouwer CD, Kostense PJ, et al. Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am J Clin Nutr. 2003;77:1192–7.10.1093/ajcn/77.5.1192Search in Google Scholar

[175] Snijder MB, Visser M, Dekker JM, Goodpaster BH, Harris TB, Kritchevsky SB, et al. Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study. Diabetologia. 2005;48:301–8.10.1007/s00125-004-1637-7Search in Google Scholar

[176] Terry RB, Stefanick ML, Haskell WL, Wood PD. Contributions of regional adipose tissue depots to plasma lipoprotein concentrations in overweight men and women: possible protective effects of thigh fat. Metabolism. 1991;40:733–40.10.1016/0026-0495(91)90093-CSearch in Google Scholar

[177] Frayn KN. Adipose tissue as a buffer for daily lipid flux. Diabetologia. 2002;45:1201–10.10.1007/s00125-002-0873-ySearch in Google Scholar PubMed

[178] Foster MT, Softic S, Caldwell J, Kohli R, de Kloet AD, Seeley RJ. Subcutaneous adipose tissue transplantation in diet-induced obese mice attenuates metabolic dysregulation while removal exacerbates it. Physiological reports. 2013;1:1–12.10.1002/phy2.15Search in Google Scholar PubMed PubMed Central

[179] Koster A, Stenholm S, Alley DE, Kim LJ, Simonsick EM, Kanaya AM, et al. Body fat distribution and inflammation among obese older adults with and without metabolic syndrome. Obesity (Silver Spring). 2010;18:2354–61.10.1038/oby.2010.86Search in Google Scholar PubMed PubMed Central

[180] Pinnick KE, Nicholson G, Manolopoulos KN, McQuaid SE, Valet P, Frayn KN, et al. Distinct developmental profile of lower-body adipose tissue defines resistance against obesity-associated metabolic complications. Diabetes. 2014;63:3785–97.10.2337/db14-0385Search in Google Scholar PubMed

[181] Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821–30.10.1172/JCI200319451Search in Google Scholar

[182] Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes. 1997;46:1579–85.10.2337/diacare.46.10.1579Search in Google Scholar PubMed

[183] Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest. 1995;96:88–8.10.1172/JCI118083Search in Google Scholar PubMed PubMed Central

[184] Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, Adams PW. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab. 1982;54:254–60.10.1210/jcem-54-2-254Search in Google Scholar PubMed

[185] Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest. 1983;72:1150–62.10.1172/JCI111040Search in Google Scholar PubMed PubMed Central

[186] Salans LB, Knittle JL, Hirsch J. The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity. J Clin Invest. 1968;47:153–65.10.1172/JCI105705Search in Google Scholar PubMed PubMed Central

[187] Salans LB, Cushman SW, Weismann RE. Studies of human adipose tissue. Adipose cell size and number in nonobese and obese patients. J Clin Invest. 1973;52:929–41.10.1172/JCI107258Search in Google Scholar PubMed PubMed Central

[188] Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia. 2000;43:1498–506.10.1007/s001250051560Search in Google Scholar PubMed

[189] Cancello R, Zulian A, Gentilini D, Maestrini S, Della Barba A, Invitti C, et al. Molecular and morphologic characterization of superficial- and deep-subcutaneous adipose tissue subdivisions in human obesity. Obesity (Silver Spring). 2013;21:2562–70.10.1002/oby.20417Search in Google Scholar PubMed

[190] Golan R, Shelef I, Rudich A, Gepner Y, Shemesh E, Chassidim Y, et al. Abdominal superficial subcutaneous fat: a putative distinct protective fat subdepot in type 2 diabetes. Diabetes Care. 2012;35:640–7.10.2337/dc11-1583Search in Google Scholar PubMed PubMed Central

[191] Kim SH, Chung JH, Song SW, Jung WS, Lee YA, Kim HN. Relationship between deep subcutaneous abdominal adipose tissue and metabolic syndrome: a case control study. Diabetol Metab Syndr. 2016;8:10.10.1186/s13098-016-0127-7Search in Google Scholar PubMed PubMed Central

[192] Cox-York K, Wei Y, Wang D, Pagliassotti MJ, Foster MT. Lower body adipose tissue removal decreases glucose tolerance and insulin sensitivity in mice with exposure to high fat diet. Adipocyte. 2015;4:32–43.10.4161/21623945.2014.957988Search in Google Scholar PubMed PubMed Central

[193] Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev. 1994;74:761–811.10.1152/physrev.1994.74.4.761Search in Google Scholar PubMed

[194] Miyazaki Y, DeFronzo RA. Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type. Cardiovasc Diabetol. 2009;8:44.10.1186/1475-2840-8-44Search in Google Scholar PubMed PubMed Central

[195] Gastaldelli A, Sironi AM, Ciociaro D, Positano V, Buzzigoli E, Giannessi D, et al. Visceral fat and beta cell function in non-diabetic humans. Diabetologia. 2005;48:2090–6.10.1007/s00125-005-1891-3Search in Google Scholar PubMed

[196] Kim S, Cho B, Lee H, Choi K, Hwang SS, Kim D, et al. Distribution of abdominal visceral and subcutaneous adipose tissue and metabolic syndrome in a Korean population. Diabetes Care. 2011;34:504–6.10.2337/dc10-1364Search in Google Scholar PubMed PubMed Central

[197] Kaess BM, Pedley A, Massaro JM, Murabito J, Hoffmann U, Fox CS. The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk. Diabetologia. 2012;55:2622–30.10.1007/s00125-012-2639-5Search in Google Scholar PubMed PubMed Central

[198] He H, Ni Y, Chen J, Zhao Z, Zhong J, Liu D, et al. Sex difference in cardiometabolic risk profile and adiponectin expression in subjects with visceral fat obesity. Transl Res. 2010;155:71–7.10.1016/j.trsl.2009.08.003Search in Google Scholar PubMed

[199] Yeoh AJ, Pedley A, Rosenquist KJ, Hoffmann U, Fox CS. The association between subcutaneous fat density and the propensity to store fat viscerally. J Clin Endocrinol Metab. 2015;100:E1056–64.10.1210/jc.2014-4032Search in Google Scholar PubMed PubMed Central

[200] Pessin JE, Kwon H. How does high-fat diet induce adipose tissue fibrosis? J Investig Med. 2012;60:1147–50.10.2310/JIM.0b013e318271fdb9Search in Google Scholar PubMed PubMed Central

[201] Suganami T, Tanaka M, Ogawa Y. Adipose tissue inflammation and ectopic lipid accumulation. Endocr J. 2012;59:849–57.10.1507/endocrj.EJ12-0271Search in Google Scholar

[202] Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259:87–91.10.1126/science.7678183Search in Google Scholar PubMed

[203] Gray SL, Vidal-Puig AJ. Adipose tissue expandability in the maintenance of metabolic homeostasis. Nutr Rev. 2007;65:S7–12.10.1111/j.1753-4887.2007.tb00331.xSearch in Google Scholar PubMed

[204] Foster MT. So as we worry we weigh: visible burrow system stress and visceral adiposity. Physiol Behav. 2017;178:151–6.10.1016/j.physbeh.2017.01.019Search in Google Scholar PubMed

[205] Weber RV, Buckley MC, Fried SK, Kral JG. Subcutaneous lipectomy causes a metabolic syndrome in hamsters. Am J Physiol Regul Integr Comp Physiol. 2000;279:R936–43.10.1152/ajpregu.2000.279.3.R936Search in Google Scholar PubMed